Literature DB >> 15919417

Effect of lysophosphatidylcholine on vasomotor functions of porcine coronary arteries.

Rakesh Safaya1, Hong Chai, Panagiotis Kougias, Peter Lin, Alan Lumsden, Qizhi Yao, Changyi Chen.   

Abstract

BACKGROUND: Lysophosphatidylcholine (LPC) is a product of phosphatidylcholine hydrolysis by phospholipase A(2) and a mediator of the lipid-induced atherosclerotic changes. In this study, we determined the effects of LPC on vasomotor functions, oxidative stress, and endothelial nitric oxide synthase (eNOS) expression in porcine coronary arteries.
METHODS: Porcine coronary arteries were cut into 5-mm rings and were treated with LPC or antioxidant selenomethionine (SeMet). For the vasomotor studies, we used a myograph tension system. Levels of superoxide anion (O(2)(-)) were detected by the lucigenin-enhanced chemiluminescence method. The eNOS protein level was studied by immunohistochemistry with avidin-biotin complex immunoperoxidase procedure.
RESULTS: Endothelium-dependent relaxation in response to bradykinin was reduced by 36% and 81% for the rings treated with 12.5 and 25 mum of LPC, respectively, as compared with controls (P < 0.05). Endothelium-independent relaxation in response to sodium nitroprusside also was reduced by 63% after treatment with 25 mum LPC (P < 0.05). The O(2)(-) level was increased in the porcine arteries treated with 25 mum of LPC by 41% as compared with controls (P < 0.05). The antioxidant SeMet reversed the effects of LPC on vascular relaxation and O(2)(-) production. Immunoreactivity of eNOS in LPC-treated vessel rings also was reduced substantially.
CONCLUSIONS: LPC impairs endothelium-dependent and endothelium-independent vasorelaxation. This effect is associated with increased superoxide radical production and decreased eNOS activity and is practically reversed with the use of the antioxidant SeMet.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919417     DOI: 10.1016/j.jss.2005.01.015

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

1.  Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk.

Authors:  Kenneth J Colley; Robert L Wolfert; Michael E Cobble
Journal:  EPMA J       Date:  2011-03-10       Impact factor: 6.543

2.  Chlamydia heat shock protein 60 decreases expression of endothelial nitric oxide synthase in human and porcine coronary artery endothelial cells.

Authors:  Changyi Chen; Hong Chai; Xinwen Wang; Peter H Lin; Qizhi Yao
Journal:  Cardiovasc Res       Date:  2009-05-14       Impact factor: 10.787

Review 3.  Lipoprotein-associated phospholipase A(2) : review of its role as a marker and a potential participant in coronary endothelial dysfunction.

Authors:  Shahar Lavi; Ronit Lavi; Joseph P McConnell; Lilach O Lerman; Amir Lerman
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

4.  Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells.

Authors:  Changyi Chen; Hong Chai; Xinwen Wang; Jun Jiang; Md Saha Jamaluddin; Dan Liao; Yuqing Zhang; Hao Wang; Uddalak Bharadwaj; Sheng Zhang; Min Li; Peter Lin; Qizhi Yao
Journal:  Blood       Date:  2008-07-24       Impact factor: 22.113

5.  Protective effects of EPA and deleterious effects of DHA on eNOS activity in Ea hy 926 cultured with lysophosphatidylcholine.

Authors:  Sylviane Tardivel; Aurélie Gousset-Dupont; Véronique Robert; Marie-Luce Pourci; Alain Grynberg; Bernard Lacour
Journal:  Lipids       Date:  2009-02-04       Impact factor: 1.880

6.  GPR55 agonist lysophosphatidylinositol and lysophosphatidylcholine inhibit endothelial cell hyperpolarization via GPR-independent suppression of Na+-Ca2+ exchanger and endoplasmic reticulum Ca2+ refilling.

Authors:  Alexander I Bondarenko; Fabrizio Montecucco; Olga Panasiuk; Vadim Sagach; Nataliya Sidoryak; Karim J Brandt; François Mach
Journal:  Vascul Pharmacol       Date:  2017-01-05       Impact factor: 5.773

7.  Soluble guanylate cyclase redox state under oxidative stress conditions in isolated monkey coronary arteries.

Authors:  Masashi Tawa; Tomio Okamura
Journal:  Pharmacol Res Perspect       Date:  2016-09-16

8.  Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients.

Authors:  Giuseppe Maiolino; Luigi Pedon; Maurizio Cesari; Anna Chiara Frigo; Robert L Wolfert; Marlena Barisa; Leopoldo Pagliani; Giacomo Rossitto; Teresa Maria Seccia; Mario Zanchetta; Gian Paolo Rossi
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

9.  Lysophosphatidylcholine up-regulates human endothelial nitric oxide synthase gene transactivity by c-Jun N-terminal kinase signalling pathway.

Authors:  Feiyue Xing; Jing Liu; Yongyan Mo; Zhifeng Liu; Qinghe Qin; Jingzhen Wang; Zhenhua Fan; Yutian Long; Na Liu; Kesen Zhao; Yong Jiang
Journal:  J Cell Mol Med       Date:  2008-06-20       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.